LEO Pharma A/S, a global leader in medical dermatology, today presented two late-breaking presentations showcasing the results of a Phase 2b dose finding trial evaluating the efficacy and safety of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback